O. Adetunji

Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes: Past, present, and future

S. Kalra, M. Baruah, R. Sahay, 2016, Indian journal of endocrinology and metabolism.

A joint industry‐sponsored data monitoring committee model for observational, retrospective drug safety studies in the real‐world setting

A. Neugut, J. Massaro, J. Sosa, 2020, Pharmacoepidemiology and Drug Safety.

Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir

S. Heller, M. Davies, J. Vora, 2013, Diabetes Care.

Physician perceptions of GLP-1 receptor agonists in the UK

L. Matza, K. Boye, Sherry A. Martin, 2016, Current medical research and opinion.